The present invention relates to a method for producing patient cancerous disease modifying antibodies using a novel paradigm of screening. An intermediate state reached by the current task is saved when the interrupt request occurs, and a counter for each of the processors indicating a number of instructions processed by each of the processors is maintained. A valve is movable in the valve body along an axis to control fluid flow between the first and the second flow passages. In other words, the charge removing device attains a good durability for a long time. For example, the circuitry can include a decode array coupled with the antennas, and a decoder coupled with the decode array. The application is executed by a virtual client of a first server.